Invest Now

or promote your offering.

  • Medical 21, Inc.

    Is offering up to $40,000,000.00 USD

    under 4(a)(2) (Reg A+) for a Equity offering.

    Closing on April 01, 2023

    Medical 21 offers a groundbreaking medtech innovation — the MAVERICS graft system. This artificial vein has the potential to revolutionize the cardiac bypass surgery procedure and enhance the quality of life and recovery for millions of patients.